Back | Next |
home / stock / acrs / acrs message board
Subject | By | Source | When |
---|---|---|---|
3 Best Penny Stocks To Trade Before Next | jonny_red | investorshub | 10/28/2019 2:34:19 PM |
~2.00+ SQUUUUEEEEEZEEE | VMB-1 | investorshub | 10/25/2019 3:31:57 PM |
~in @1.83...Gonna Spike new HOD.. | VMB-1 | investorshub | 10/25/2019 1:57:46 PM |
the shorts will have to cover over 4mm | dndodd | investorshub | 10/25/2019 1:19:50 PM |
Sold 1/3 of shares in after market @ | Neverland66 | investorshub | 10/25/2019 12:46:47 PM |
WOW!! | toybaby | investorshub | 10/25/2019 12:05:37 PM |
~Buy AfterHours for another Halt Spike AM 2morrow? | VMB-1 | investorshub | 10/24/2019 10:45:39 PM |
Positive phase 3 news just out ! | stock1ace1 | investorshub | 10/24/2019 9:02:15 PM |
News ! | stock1ace1 | investorshub | 10/24/2019 8:51:43 PM |
* * $ACRS Video Chart 10-22-2019 * * | ClayTrader | investorshub | 10/22/2019 8:17:40 PM |
1.73 | toybaby | investorshub | 10/17/2019 11:32:27 AM |
We should see $2.08 as next resistance | AugustaFriends | investorshub | 10/16/2019 12:40:56 PM |
1.70 p/m | stock1ace1 | investorshub | 10/16/2019 12:22:09 PM |
I am impressed | toybaby | investorshub | 10/16/2019 11:16:32 AM |
Arkin Moshe discloses 8.02% activist ownership in $ACRS | ADVFN_bioking | investorshub | 10/15/2019 9:40:46 PM |
1.50 up | toybaby | investorshub | 10/15/2019 5:46:22 PM |
I still do things like that I sold | toybaby | investorshub | 10/15/2019 12:29:50 PM |
A novice trader sold pm @1.25 im dead | stock1ace1 | investorshub | 10/15/2019 12:06:35 PM |
Easily attainable | toybaby | investorshub | 10/15/2019 12:00:43 PM |
Need to push thru 1.50$ today | stock1ace1 | investorshub | 10/15/2019 11:41:25 AM |
News, Short Squeeze, Breakout and More Instantly...
Aclaris Therapeutics Inc. Company Name:
ACRS Stock Symbol:
NASDAQ Market:
Aclaris Therapeutics Inc. Website:
- Non-Dilutive Transaction Strengthens Balance Sheet to Support Strategic Priorities - - $26.5 Million Upfront Plus Up to $5.0 Million Milestone - WAYNE, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company ...
WAYNE, Pa., June 06, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, Interim President & CEO of Aclaris, will part...
- Progressing ATI-2138 into Atopic Dermatitis - - Management to Host Conference Call at 5:00 PM ET Today - WAYNE, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidat...